Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Coronavirus Notebook: UK Reveals Plans For Pre-Approval Use Of COVID-19 Vaccine

Executive Summary

The UK government is proposing to take the "very unusual step" of making COVID-19 vaccines available before they are licensed. The international COVAX initiative is now supporting nine vaccines, and the EU and AstraZeneca have firmed up a vaccine purchase agreement.  

You may also be interested in...



Coronavirus Notebook: EU Joins COVAX, Sanofi/GSK Vaccine Moves To Phase I/II

Convalescent plasma has taken another battering as a potential treatment for coronavirus patients, after a UK drug safety body agreed with a US expert panel that there was not yet enough evidence to recommend its use in COVID-19 patients. 

BIA Applauds UK Plan For Pre-Approval Use Of Coronavirus Vaccine

The UK can already OK the use of unapproved products, but the government wants more certainty around the conditions that will be attached to any decision to make COVID-19 vaccines available before they have been licensed. Moves are also under way to reassure pharmaceutical companies about liability issues.

Coronavirus Notebook: EU In More Vaccine Talks, HTA Rolling Reviews, and RECOVERY’s UK Expansion

The European Commission is in talks to buy vaccines from CureVac and Moderna, amid concerns over “vaccine nationalism” and lack of transparency. Meanwhile the EU health technology assessment network has begun publishing “rolling collaborative reviews” of potential COVID-19 therapies, and two more firms have announced progress with monoclonal antibodies. 

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

LL1133833

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel